Last reviewed · How we verify
Artemisia vulgaris
Artemisia vulgaris is a herbal preparation that may exert anti-inflammatory and immunomodulatory effects through its volatile oils and sesquiterpene lactones.
Artemisia vulgaris is a herbal preparation that may exert anti-inflammatory and immunomodulatory effects through its volatile oils and sesquiterpene lactones. Used for Allergic rhinitis and related allergic conditions.
At a glance
| Generic name | Artemisia vulgaris |
|---|---|
| Also known as | Four different concentrations of Artemisia vulgaris allergen extract, positive control and negative control |
| Sponsor | Laboratorios Leti, S.L. |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Artemisia vulgaris (mugwort) contains bioactive compounds including artemisinin-related sesquiterpenes and essential oils that have been traditionally used to modulate immune responses and reduce inflammation. The exact molecular mechanisms in humans remain incompletely characterized, though in vitro studies suggest potential effects on inflammatory cytokine production and immune cell activation.
Approved indications
- Allergic rhinitis and related allergic conditions
Common side effects
- Contact dermatitis
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Safety and Efficacy of Herbal Tea in Type 2 Diabetics (NA)
- Determination of Biological Activity of Three Allergen Extracts (PHASE2)
- Warm Needle Acupuncture vs Needle Acupuncture (NA)
- To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction. (PHASE2)
- Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Artemisia vulgaris CI brief — competitive landscape report
- Artemisia vulgaris updates RSS · CI watch RSS
- Laboratorios Leti, S.L. portfolio CI